Monte Rosa Therapeutics, Inc. - stock earnings
Stock symbol GLUE is outdated, potentially delisted? Maybe it is available on other exchange?
GLUE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -30.8 million USD | ? USD |
| 2022Q3 | -27.3 million USD | ? USD |
| 2022Q2 | -26.5 million USD | ? USD |
| 2022Q1 | -23.9 million USD | ? USD |
| 2021Q4 | -23.4 million USD | ? USD |
| 2021Q3 | -19.8 million USD | ? USD |
| 2021Q2 | -18.4 million USD | ? USD |
| 2021Q1 | -12.3 million USD | ? USD |
| 2020Q3 | -6.6 million USD | ? USD |
GLUE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -108.5 million USD | ? USD |
| 2021 | -74.0 million USD | ? USD |
| 2020 | -35.9 million USD | ? USD |
| 2019 | -92.9 million USD | ? USD |
GLUE
Price: $5.65
52 week price:
Earnings Per Share: -2.69 USD
P/E Ratio: -1.61
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 41268
Market Capitalization: 216.9 million